我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

对比剂碘克沙醇对轻中度肾功能不全伴Ⅱ型糖尿病患者血清肌酐的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2012年第2期
页码:
244-246
栏目:
临床研究
出版日期:
2012-04-25

文章信息/Info

Title:
Effect of iodixanol on serum creatinine of patients with mild or moderate renal dysfunction and type II diabetes
作者:
双东思; 苏 晞; 朱国英; 宋显静; 蔡建华
(武汉亚洲心脏病医院心内科，湖北 武汉 430022)
Author(s):
SHUANG Dong-si;  SU Xi;  ZHU Guo-ying;  SONG Xian-jing;  CAI Jian-hua
(Department of Cardiology, Wuhan Asia Heart Hospital, Wuhan 430022, Hubei, China)
关键词:
碘克沙醇; 心血管造影; 对比剂肾病
Keywords:
iodixanol;  cardiovascular angiographic;  contrast-induced nephropathy
分类号:
R814.43
DOI:
-
文献标识码:
A
摘要:
目的:观察对比剂碘克沙醇(威视派克) 对肾功能不全并发糖尿病患者血清肌酐的影响，以探讨其临床使用的安全性。方法：选取2009年1月20日~2010年4月20日于我院行心血管造影的Ⅱ型糖尿病并发轻-中度肾功能不全的患者84例,观察术前、术后各项指标的变化，对造影前后数据进行配对资料统计分析。结果：术后3 d血清肌酐（SCr）较基线水平显著增加［(97±20) μmol/L vs.(95±20) μmol/L,P<0.05］,术后2 d SCr:(95±21) μmol/L,术后3 d较术后2 d SCr略有升高（P<0.05）。结论：碘克沙醇用于Ⅱ型糖尿病并发轻-中度肾功能不全的患者仅轻度增加SCr，使用是安全的。
Abstract:
AIM:To observe the effect of iodixanol on serum creatinine of patients with mild or moderate renal dysfunction and type II diabetes (T2D) and to examine the safety of iodixanol. METHODS: Included in the study were 84 patients with mild or moderate renal dysfunction and T2D undergoing cardiovascular angiography at the Wuhan Asian Heart Hospital. Paired data before and after cardiovascular angiography were compared using t test. RESULTS: Serum creatinine (Scr) at 3 days postoperatively significantly increased (2.5%) compared with baseline ［(97±20) μmol/L vs. (95±20) μmol/L, P<0.05］. Scr at 3 days postsurgery significantly increased (2.1%) compared with that 2 days postsurgery ［(97±20) μmol/L vs. (95±21) μmol/L, P<0.05］. CONCLUSION: Lodixanol can be used in patients with mild or moderate renal dysfunction and type II diabetes and only slightly increases Scr.

参考文献/References

[1]Nash K,Hafeez A,Hou S.Hospital-acquired renal insufficiency[J].Am J Kidney Dis,2002,39(5):930-936.

[2]Aspelin P,Aubry P,Fransson SG,et al.Nephrotoxic effects in high-risk patients undergoing angiography[J].N Engl J Med,2003,348(6):491-499.

[3]Richard J,Madhu K,Serge Doucet,et al.Cardiac angiography in renally impaired patitient(CARE)study:a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease[J].Circulation,2007, 115(25):3189-3196.

[4]Nikolsky E,Mehran R,Turcot D,el al.Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention[J].Am J Cardiol,2004,94(3):300-305.

[5]Kurnik BR,Allgren RL,Genter FC,et al.Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy［[J].Am J Kidney Dis,1998,31(4):674-680.

[6]Lautin EM,Freeman NJ,Schoenfeld AH,et al.Radiocontrast-associated renal dysfunction: incidence and risk factors[J].Am J Roentgenol,1991,157(1):49-58.

[7]From AM,Al Badarin FJ,McDonald FS,et al.Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials[J].Cir Cardiovasc Interv,2010,3(4):351-358.

[8]Jo SH,Youn TJ,Koo BK,et al.Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography:the RECOVER study:a randomized controlled trial[J].J Am Coll Cardiol,2006,48 (5):924-930.

[9]Maioli M,Toso A,Leoncini M,et al.Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention[J].J Am Coll Cardiol,2008,52(8):599-604.

[10]Barrett BJ,Parfrey PS.Preventing nephropathy induced by contrast medium[J].N Engl J Med,2006,354(4):379-386.

[11]Laskey W,Aspelin P,Davidson C,et al.Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures[J].Am Heart J,2009,158(5):822-828,e3.

备注/Memo

备注/Memo:
收稿日期：2010-09-06.作者简介：双东思，主治医师，硕士 Email:sds97@163.com
更新日期/Last Update: 2012-04-01